These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 23515246)

  • 21. Application of a rat osteomyelitis model to compare in vivo and in vitro the antibiotic efficacy against bacteria with high capacity to form biofilms.
    Gracia E; Laclériga A; Monzón M; Leiva J; Oteiza C; Amorena B
    J Surg Res; 1998 Oct; 79(2):146-53. PubMed ID: 9758730
    [TBL] [Abstract][Full Text] [Related]  

  • 22. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
    Ooi N; Miller K; Randall C; Rhys-Williams W; Love W; Chopra I
    J Antimicrob Chemother; 2010 Jan; 65(1):72-8. PubMed ID: 19889790
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of extra-cellular fatty acids in vancomycin induced biofilm formation by vancomycin resistant Staphylococcus aureus.
    Mirani ZA; Jamil N
    Pak J Pharm Sci; 2013 Mar; 26(2):383-9. PubMed ID: 23455211
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of biofilm-associated cell survival following in vitro exposure of meticillin-resistant Staphylococcus aureus biofilms to the antibiotics clindamycin, daptomycin, linezolid, tigecycline and vancomycin.
    Smith K; Perez A; Ramage G; Gemmell CG; Lang S
    Int J Antimicrob Agents; 2009 Apr; 33(4):374-8. PubMed ID: 19101124
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Viable but non-culturable (VBNC) bacteria: Gene expression in planktonic and biofilm cells.
    Trevors JT
    J Microbiol Methods; 2011 Aug; 86(2):266-73. PubMed ID: 21616099
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Bridging the gap between viable but non-culturable and antibiotic persistent bacteria.
    Ayrapetyan M; Williams TC; Oliver JD
    Trends Microbiol; 2015 Jan; 23(1):7-13. PubMed ID: 25449050
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High in vitro antimicrobial activity of synthetic antimicrobial peptidomimetics against staphylococcal biofilms.
    Flemming K; Klingenberg C; Cavanagh JP; Sletteng M; Stensen W; Svendsen JS; Flaegstad T
    J Antimicrob Chemother; 2009 Jan; 63(1):136-45. PubMed ID: 19010828
    [TBL] [Abstract][Full Text] [Related]  

  • 28. RNAIII-inhibiting peptide significantly reduces bacterial load and enhances the effect of antibiotics in the treatment of central venous catheter-associated Staphylococcus aureus infections.
    Cirioni O; Giacometti A; Ghiselli R; Dell'Acqua G; Orlando F; Mocchegiani F; Silvestri C; Licci A; Saba V; Scalise G; Balaban N
    J Infect Dis; 2006 Jan; 193(2):180-6. PubMed ID: 16362881
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A comparative in-vitro evaluation of resistance selection after exposure to teicoplanin, vancomycin, linezolid and quinupristin-dalfopristin in Staphylococcus aureus and Enterococcus spp.
    Drago L; Nicola L; De Vecchi E
    Clin Microbiol Infect; 2008 Jun; 14(6):608-11. PubMed ID: 18397336
    [TBL] [Abstract][Full Text] [Related]  

  • 30. In vitro activity of mupirocin on clinical isolates of Staphylococcus aureus and its potential implications in chronic rhinosinusitis.
    Ha KR; Psaltis AJ; Butcher AR; Wormald PJ; Tan LW
    Laryngoscope; 2008 Mar; 118(3):535-40. PubMed ID: 18090864
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The silver cation (Ag+): antistaphylococcal activity, mode of action and resistance studies.
    Randall CP; Oyama LB; Bostock JM; Chopra I; O'Neill AJ
    J Antimicrob Chemother; 2013 Jan; 68(1):131-8. PubMed ID: 23011288
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Telavancin: in vitro activity against staphylococci in a biofilm model.
    Gander S; Kinnaird A; Finch R
    J Antimicrob Chemother; 2005 Aug; 56(2):337-43. PubMed ID: 15972312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Activities of antistaphylococcal antibiotics towards the extracellular and intraphagocytic forms of Staphylococcus aureus isolates from a patient with persistent bacteraemia and endocarditis.
    Lemaire S; Kosowska-Shick K; Julian K; Tulkens PM; Van Bambeke F; Appelbaum PC
    Clin Microbiol Infect; 2008 Aug; 14(8):766-77. PubMed ID: 18727801
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recent findings on the viable but nonculturable state in pathogenic bacteria.
    Oliver JD
    FEMS Microbiol Rev; 2010 Jul; 34(4):415-25. PubMed ID: 20059548
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Time-kill kinetics of quinupristin/dalfopristin on Staphylococcus aureus with and without a raised MBC evaluated by two methods.
    Boswell FJ; Sunderland J; Andrews JM; Wise R
    J Antimicrob Chemother; 1997 May; 39 Suppl A():29-32. PubMed ID: 9511059
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro evaluation of the antibiotic lock technique (ALT) for the treatment of catheter-related infections caused by staphylococci.
    Lee JY; Ko KS; Peck KR; Oh WS; Song JH
    J Antimicrob Chemother; 2006 Jun; 57(6):1110-5. PubMed ID: 16556639
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Anoxia inhibits biofilm development and modulates antibiotic activity.
    Hess DJ; Henry-Stanley MJ; Lusczek ER; Beilman GJ; Wells CL
    J Surg Res; 2013 Sep; 184(1):488-94. PubMed ID: 23746961
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Activities of the combination of quinupristin-dalfopristin with rifampin in vitro and in experimental endocarditis due to Staphylococcus aureus strains with various phenotypes of resistance to macrolide-lincosamide-streptogramin antibiotics.
    Zarrouk V; Bozdogan B; Leclercq R; Garry L; Feger C; Carbon C; Fantin B
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1244-8. PubMed ID: 11257041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Linezolid and quinupristin/dalfopristin resistance in vancomycin-resistant enterococci and methicillin-resistant Staphylococcus aureus prior to clinical use in Turkey.
    Baysallar M; Kilic A; Aydogan H; Cilli F; Doganci L
    Int J Antimicrob Agents; 2004 May; 23(5):510-2. PubMed ID: 15120733
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of a solution containing citrate/Methylene Blue/parabens on Staphylococcus aureus bacteria and biofilm, and comparison with various heparin solutions.
    Sauer K; Steczko J; Ash SR
    J Antimicrob Chemother; 2009 May; 63(5):937-45. PubMed ID: 19282330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.